Home » Authors » Trista Morrison

Articles by Trista Morrison

Roche Ends 10-Year Court Fight By Acquiring BioVeris For $600M

April 5, 2007

By Trista Morrison

Syndax Gets $40M Series A To Build Cancer Combo Pipeline

April 4, 2007

By Trista Morrison

Syndax Gets $40M Series A To Build Cancer Combo Pipeline

April 4, 2007

By Trista Morrison

Roche Acquires Therapeutic Human Polyclonals For $56.5M

April 3, 2007

By Trista Morrison

Roche Acquires Therapeutic Human Polyclonals For $56.5M

April 3, 2007

By Trista Morrison

Vivus Gets Up To $180M From KV Pharma For Hot Flash Drug

April 2, 2007

By Trista Morrison

FDA Wants Another Phase III For NeoPharm's GBM Drug

March 30, 2007

By Trista Morrison

FDA Wants Another Phase III For NeoPharm's GBM Drug

March 30, 2007

By Trista Morrison

Samaritan, Pharmaplaz Partner On Phase II HIV Drug SP-01A

March 29, 2007

By Trista Morrison

Samaritan, Pharmaplaz Partner On Phase II HIV Drug SP-01A

March 29, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...